POLITICS, PROFITS AND INNOVATION IN THE DRUG INDUSTRY

Joseph L. Zentner

Review of Policy Research, 1984, vol. 3, issue 3‐4, 496-499

Abstract: Henry G. Grabowski and John M. Vernon. The Regulation of Pharmaceuticals: Balancing the Benefits and Risks Meir Statman. Competition in the Pharmaceutical Industry: The Declining Profitability of Drug Innovation Milton Silverman, Philip R. Lee and Mia Lydecker. Prescriptions for Death: The Drugging of the Third World

Date: 1984
References: Add references at CitEc
Citations:

Downloads: (external link)
https://doi.org/10.1111/j.1541-1338.1984.tb00147.x

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:bla:revpol:v:3:y:1984:i:3-4:p:496-499

Ordering information: This journal article can be ordered from
http://www.wiley.com/bw/subs.asp?ref=1541-132x

Access Statistics for this article

Review of Policy Research is currently edited by Christopher Gore

More articles in Review of Policy Research from Policy Studies Organization Contact information at EDIRC.
Bibliographic data for series maintained by Wiley Content Delivery ().